[go: up one dir, main page]

KR890702037A - 간장암 질환의 진단법 - Google Patents

간장암 질환의 진단법

Info

Publication number
KR890702037A
KR890702037A KR1019890701032A KR890701032A KR890702037A KR 890702037 A KR890702037 A KR 890702037A KR 1019890701032 A KR1019890701032 A KR 1019890701032A KR 890701032 A KR890701032 A KR 890701032A KR 890702037 A KR890702037 A KR 890702037A
Authority
KR
South Korea
Prior art keywords
cancer disease
diagnosis
liver cancer
monoclonal antibodies
nazeinviter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019890701032A
Other languages
English (en)
Other versions
KR920002182B1 (ko
Inventor
교오이치 이노우에
다카후미 이치다
미키 미야기와
타로오 하야카와
슈우지 고다마
가즈시 이와타
Original Assignee
다케다 유우이치로오
후지야쿠힝 고오교오 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다케다 유우이치로오, 후지야쿠힝 고오교오 가부시끼 가이샤 filed Critical 다케다 유우이치로오
Publication of KR890702037A publication Critical patent/KR890702037A/ko
Application granted granted Critical
Publication of KR920002182B1 publication Critical patent/KR920002182B1/ko
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

간장암 질환의 진단법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도에 나타낸 것으로 명백한바와 같이 상기의모노크로널 항체는 어는 것이나 소의 치수 콜라게나아제 인히비터와 교차하는 것을 알았다.
제2도에 나타낸 바와같이, 첨가한 소의 치수 콜라게나아제 인히비터량과 A450사이에 직선관계가 성립하고, 정량감도는 시험관당 약 1pg(32 a mol)이었다.
제3도는 웨스턴 블로팅 뒤에 니트로 셀룰로우즈막을 1 ;크론7-3F1, 2 ;크론7-6C1, 3 :7-19F6, 4 : 크론7-21B12 및 5 : 크론 7-23G9의 각모노크로널 항체로부터 조제한 Fab'-POD 복합체로 면역염색을 행할 결과를 나타 낸 것이다.

Claims (1)

  1. 콜라게나아제 인히비터의 다른 항원 결정기에 대하여, 특이적으로 결합하는 2종류의 모노크로널 항체의 조합을 이용한 샌드위치법에 의하여, 효소 면역학적으로 혈청중, 혈장중 혹은 관절책중에 존재하는 콜라게나아제인히 비터를 정량하고, 그 정량치를 건강한 사람의값과 비교하는 것을 특징으로 하는 간장암 질환의진단법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890701032A 1987-10-30 1988-10-28 간장암질환의 진단법 Expired KR920002182B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP273265 1987-10-30
JP87-273265 1987-10-30
JP27326587 1987-10-30
PCT/JP1988/001103 WO1989003997A1 (fr) 1987-10-30 1988-10-28 Methode de diagnostic du cancer du foie

Publications (2)

Publication Number Publication Date
KR890702037A true KR890702037A (ko) 1989-12-22
KR920002182B1 KR920002182B1 (ko) 1992-03-19

Family

ID=17525424

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890701032A Expired KR920002182B1 (ko) 1987-10-30 1988-10-28 간장암질환의 진단법

Country Status (5)

Country Link
US (1) US5175084A (ko)
EP (1) EP0339097B1 (ko)
KR (1) KR920002182B1 (ko)
DE (1) DE3850962T2 (ko)
WO (1) WO1989003997A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003087766A2 (en) * 2002-04-05 2003-10-23 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets
US9944713B2 (en) 2004-11-24 2018-04-17 Medicinal Bioconvergence Research Center Antibody specific to the AIMP2-DX2
US20130085075A1 (en) * 2011-06-06 2013-04-04 Meso Scale Technologies, Llc Diagnostic methods for liver disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH642458A5 (en) * 1980-04-25 1984-04-13 Hoffmann La Roche Immunological method
CA1160566A (en) * 1980-04-25 1984-01-17 Harald Gallati Immunological determination method
JP2609858B2 (ja) * 1987-02-27 1997-05-14 富士薬品工業 株式会社 コラゲナーゼインヒビターの酵素免疫学的定量法
WO1989002078A1 (fr) * 1987-08-25 1989-03-09 Fuji Yakuhin Kogyo Kabushiki Kaisha Procede de diagnostic de rhumatismes articulaires chroniques
JP3278007B2 (ja) * 1993-02-20 2002-04-30 ティーディーケイ株式会社 スイッチング電源

Also Published As

Publication number Publication date
EP0339097B1 (en) 1994-08-03
EP0339097A4 (en) 1990-12-05
EP0339097A1 (en) 1989-11-02
US5175084A (en) 1992-12-29
KR920002182B1 (ko) 1992-03-19
DE3850962D1 (de) 1994-09-08
WO1989003997A1 (fr) 1989-05-05
DE3850962T2 (de) 1994-12-22

Similar Documents

Publication Publication Date Title
US4609629A (en) Process for the immunological determination of proteins in body fluid which display a non-parallel inhibition curve to a reference inhibitor
Hidayat et al. Enzyme linked immunosorbent assay (ELISA) technique guideline
ES2145924T3 (es) Procedimiento para detectar anticuerpos.
BRPI0410261B8 (pt) anticorpo monoclonal que se liga especificamente ao probnp, métodos para detecção específica de probnp in vitro e para diagnóstico de insuficiência cardíaca in vitro, kit para medição de probnp, e linhagem celular de hibridoma mab 1.21.3
DK196282A (da) Fremgangsmaade samt kit til bestemmelse af antistoffer mod oploeselige antigener
ES2070488T3 (es) Procedimiento para la deteccion de enfermedades malignas.
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
DE69018968D1 (de) BLUTGERINNUNGSFAKTOR BETA XIIa MONOKLONALE ANTIKÖRPER UND IMMUNANALYSE.
SE7714034L (sv) Forfarande for enzymkopplad immunoanalys
KR890702037A (ko) 간장암 질환의 진단법
Avrameas Enzyme immunoassays and related techniques: development and limitations
EP0669344A3 (en) Monoclonal antibody and its use in an immunoassay.
DE59106634D1 (de) Pankreas-elastase-1-spezifischer antikörper, ein verfahren zu seiner gewinnung und ein testkit der solche antikörper enthält.
KR890008313A (ko) 안티 pci모노클론 항체
FI973418A0 (fi) Vasta-ainetuotannon toteaminen
ES8206857A1 (es) Procedimiento de deteccion de la presencia de antigenos de un grupo sanguineo a,b,0 o ab en un corte histologico
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
ATE114052T1 (de) Immunoassay zur bestimmung der bindungsspezifität eines monoklonalen antikörpers.
KR850003169A (ko) 염기성 태아단백질의 측정방법 및 시약
KR900017549A (ko) 암의 혈청진단법
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
ES2076221T3 (es) Derivados geminales de difenilo y su uso en inmunoensayos.
ES552074A0 (es) Un metodo en emparedado de doble anticuerpo para detectar o ensayar un antigeno seleccionado de urocinasa humana y un precursor de la misma
ES2168378T3 (es) Determinacion de tripsinogeno-2 libre y en forma de complejo.
ES546338A0 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse inmunologicamente

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 19990112

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20000320

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20000320

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000